| A | B | C | |
|---|---|---|---|
| 1 | Main | ||
| 2 | Brand Name | DISCONTINUED - ALKS 27 | |
| 3 | Generic Name | trospium chloride | |
| 4 | Indication | Chronic Obstructive Pulmonary Disease | |
| 5 | Mechanism | Muscarinic receptor antagonist | |
| 6 | Relaxes smooth muscle tissue to improve airflow | ||
| 7 | Administration | Inhaled. | |
| 8 | Economics | IDEV (now ENDP) returned rights. AIR technology + Indevus's trospium chloride (Sanctura) | |
| 9 | Clinical Trials | ||
| 10 | Phase IIa, COPD | ||
| 11 | n=24 | ||
| 12 | single administration of 2 dse levels and placebo | ||
| 13 | separated by washout period |